Detection of VEGF levels in ascites and peritoneal fluid

Chinese Journal of Cancer Research

Volumn 15, Issue 4, 2003, Pages 310-314

  Sun, Xiao Min ^a   Dong, Wei Guo ^a   Gao, Li Ceng ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Luoyang Refractory (Group) C LTD   (China)

Author keywords

Ascites; Enzyme linked immunoadsorbent assay; Peritoneal fluid; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASCITES; BENIGN TUMOR; CANCER INVASION; CARCINOMA; COLON CANCER; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OVARY CANCER; PERITONEAL FLUID LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; TUBERCULOSIS;

EID: 0347653728     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974898     Document Type: Article

References (14)

1. Dirix LY, Vermeulen PB, Pawinski A, et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients[J]. Br J Cancer 1997; 78: 236.
2. Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease[J]. Cancer 1999; 85: 178.
3. Zebrowski BK, Liu W, Ramirez K. Markedly elevated levels of vascular endothelial growth factor in malignant ascites[J]. Ann Surg Oncol 1999; 6: 373.
4. Yu JP, Shen ZX, Luo HS. Practical Gastroenterology (in Chinese)[M]. 1st ed. Beijing: Scientific Publishing House 1999; 1485.
5. Kabashima A, Maehara Y, Kakeji Y, et al. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma[J]. Oncology 2001; 60: 146.
6. Ishigami SI, Arii S, Furutani M, et al. Predictive value of vascular endothelial growth factor in metastasis and prognosis of human colorectal cancer[J]. Cancer 1998; 78: 1379.
7. Santin AD, Hemomat PL, Ravaggi A. Secretion of vascular endothelial growth factor in ovarian cancer[J]. Eur J Gynaecol Oncol 1999; 20: 177.
8. Yamamoto S, Konishi I, Kuroda H, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels[J]. Br J Cancer 1997; 75: 1221.
9. Yoshikawa T, Yanoma S, Tsuburaya A, et al. Antiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci[J]. Hepatogastroenterology 2000; 47: 298.
10. Aslam N, Marino CR. Malignant ascites: new concepts in pathophysiology, diagnosis, and management[J]. Arch Intem Med 2001; 161: 2733.
11. Tamsma JT, Keizer HJ, Meinders AE. Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited[J]. Ann Oncol 201; 12: 1353.
12. Stoelcker B, Echtenacher B, Weich HA, et al. VEGF/FLK-1 interaction, a requirement for malignant ascites recurrence[J]. Interferon Cytokine Res 2000; 20: 511.
13. Hasumi Y, Mizukami H, Urabe M, et al. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer[J]. Cancer Res 2002; 62: 2019.
14. Verheul HM, Hoekman K, Jorna AS, et al. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation[J]. The Oncologist 2000; 5(Suppl 1): 45.